Navigation Links
Cancer risk for kidney transplant
Date:4/30/2010

Kidney transplant recipients are known to have a higher risk of cancer, compared to the general population, due to the need to take immunosuppressive drugs to prevent organ rejection. Results published today from a significant, long-term study suggest that no single medication appears to increase this cancer risk.

Evaluating data from 1983 in a randomised trial, researchers were able review trends among 481 patients over 20 years - providing the strongest evidence to date on the issue. A total of 226 patients in the trial developed at least one cancer. By 20 years post transplant, 27% of patients developed non-skin cancer and 48% of patients developed skin cancer no one treatment had a greater effect on cancer risk.

"We found that no particular immunosuppressive drug regimen appears to increase the risk of cancer among kidney transplant patients," said lead author Dr Martin Gallagher, The George Institute.

"What we did find is that the cancer risk is driven by many factors that are known at the time of transplantation such as age and smoking history, so that patients at especially high risk can be targeted at this time", he added.

The results, which were published today in the Journal of the American Society of Nephrology, reported that non-skin cancer was associated with increasing age and smoking history; skin cancer was associated with increasing age, non-brown eye color, fairer skin, and a functioning transplant. Therefore, patients at especially high risk can be monitored more closely and use preventive measures to protect against cancer.

"Much debate has focused on the effects of various agents and dose regimens, but our analysis would suggest that cancer risk is driven by total immune suppression rather than specific medications."

More than 11,000 Australians have received a kidney transplant in the last forty years. Kidney transplant survival rates are about 90% in the first year and over 75% in five years, which mean that most kidney recipients can look forward to many years of productive life. However, it is known that patients with a kidney transplant have a 2.5 3 times higher risk of cancer than the general population.

This research analysis was undertaken by researchers from The George Institute, the University of Sydney, The Children's Hospital at Westmead, and Royal Prince Alfred Hospital Statewide Renal Services using the ANZDATA Registry.


'/>"/>

Contact: Emma Orpilla
eorpilla@george.org.au
612-823-8242
Research Australia
Source:Eurekalert

Related medicine news :

1. Targeted therapy prolongs life in patients with HER2-positive breast cancer
2. New Drugs, New Combinations Fight Breast Cancer
3. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
4. MDS Nordions TheraSphere(R) for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers
5. National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis
6. Panel calls for reducing colorectal cancer deaths by striking down barriers to screening
7. Lung Cancer: Large Impact, Little Funding
8. Inflammation marker related to obesity is elevated in patients with pancreatic cancer
9. Prolactin blocks oncogene associated with poor prognosis in breast cancer
10. Older female cancer survivors have added health issues compared to their counterparts
11. Definitive study confirms chemo benefit in postmenopausal breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... , ... A February 6 article on Healio describes a recent ... the treatments have led to significant improvements in weight loss and other health outcomes ... noted very few problematic results relating to the treatment. Beverly Hills Physicians (BHP) says ...
(Date:2/20/2017)... , ... February 20, 2017 , ... ... the rate at which women are called back for additional examinations without sacrificing ... Radiology . , In 2011, the U.S. Food and Drug Administration approved digital ...
(Date:2/20/2017)... ... February 20, 2017 , ... Daily Body ... the proper levels of “good” bacteria in the body, announced its Daily Body ... website. , Daily Body Restore® is made with a unique combination of ...
(Date:2/20/2017)... ... February 20, 2017 , ... For Immediate Release, Contact: ... leading provider of innovative software for connected home healthcare, today announced Orbita ... journey management for home healthcare. , Built on Orbita Health Cloud ...
(Date:2/20/2017)... ... February 20, 2017 , ... The StayWell Company ... care providers better manage patient health risks, foster behavior change and improve health literacy ... the world, will present a demonstration of its video capability at StayWell booth 3443 ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... 2017 Mass Spectrometer Market: Overview ... This report on mass spectrometer market ... of the market globally. The stakeholders of this ... manufacture and commercialization of various mass spectrometer instrument ... to enter this market. This report comprises an ...
(Date:2/21/2017)... Feb. 21, 2017 The global infusion pumps ... 6.0% from 2016 to 2021, to reach USD 10.84 ... Increasing prevalence of chronic diseases along with increasing geriatric ... hospital expenditure, steady increase in surgical procedural volumes, and ... some of the key factors driving the growth of ...
(Date:2/21/2017)... Auburn University College of Veterinary Medicine has become the 2 ... (HVM) Chamber.  The University of Florida has been working with ... and now Auburn University will enable its students to learn ... exclusively for the treatment of animals. HVM is ... universities like Auburn and ...
Breaking Medicine Technology: